These results demonstrated that the expression of both WT1-AS and IGF2BP2 was positively associated with tumor size (WT1-AS: p = 0.0449, IGF2BP2: p = 0.0434), and IGF2BP2 expression were also positively correlated with TNM stage (p = 0.0464). The gene discussed is WT1; the disease is neoplasm.